Staying in the field of immunology, Sfn-mediated interference with mono/dimer formation of PKM2 should be examined during Th1 or Th17 differentiation of T-helper cells (63–65), especially as Sfn already showed promise for diseases with a strong Th17 component, such as psoriasis (66) or arthritis (67). This evidence concerns the gene PKM and psoriasis.